Absence of amiloride-sensitive sodium absorption in the airway of an infant with pseudohypoaldosteronism

Journal of Pediatrics

Volumn 135, Issue 6, 1999, Pages 786-789

  Prince, Lawrence S ^a,b,c   Launspach, Janice L ^a,b,c   Geller, David S ^a,b,c   Lifton, Richard P ^a,b,c   Pratt, J Howard ^a,b,c   Zabner, Joseph ^a,b,c   Welsh, Michael J ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CHLORIDE ION; CYCLIC AMP;

ARTICLE; CASE REPORT; CHLORIDE TRANSPORT; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEWBORN; NOSE MUCOSA; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; SODIUM ABSORPTION; SWEATING; VOLTAGE CLAMP;

EID: 0033498170     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70105-8     Document Type: Article

References (26)

1. 1. Zennaro MC, Borensztein P, Soubrier F, Armanini D, Corvol P. The enigma of pseudohypoaldosteronism. Steroids 1994;59:96-9.
2. 2. Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 1994;125:752-5.
3. 3. Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996;12:248-53.
4. 4. McDonald FJ, Price MP, Snyder PM, Welsh MJ. Cloning and expression of the beta-and gamma-subunits of the human epithelial sodium channel. Am J Physiol 1995;268:C1157-63.
5. 5. Matsushita K, McCray PB, Sigmund RD, Welsh MJ, Stokes JB. Localization of epithelial sodium channel subunit mRNAs in adult rat lung by in situ hybridization. Am J Physiol 1996;271: L332-9.
6. 6. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:589-95.
7. 7. Wilson DC, Ellis L, Zielenski J, Corey M, Ip WF, Tsui LC, et al. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr 1998; 132:596-9.
8. 8. Alton EW, Currie D, Logan-Sinclair R, Warner JO, Hodson ME, Geddes DM. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J 1990;3:922-6.
9. 9. Knowles M, Gatzy J, Boucher R. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest 1983;71:1410-7.
10. 10. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993;75:207-16.
11. 11. Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, et al. Comparisons of DNA/lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 1997;100:1529-37.
12. 12. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994;79:407-14.
13. 13. Baker E, Jeunemaitre X, Portal AJ, Grimbert P, Markandu N, Persu A, et al. Abnormalities of nasal potential difference measurement in Liddle's syndrome. J Clin Invest 1998;102:10-4.
14. 14. Gowen CW, Lawson EE, Gingras-Leatherman J, Gatzy JT, Boucher RC, Knowles MR. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis. J Pediatr 1986;108:517-21.
15. 15. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1996;6:445-55.
16. 16. Strautnieks SS, Thompson RJ, Gardiner RM, Chung E. A novel splice-site mutation in the α subunit of the epithelial sodium channel gene in three pseudohypoalclosteronism type 1 families. Nat Genet 1996;13:248-50.
17. + channel is made of three homologous subunits. Nature 1994; 567:463-7.
18. 18. Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 1997;77:359-96.
19. 19. Bosson D, Kuhnle U, Mees N, Ramet J, Vamos E, Vertongen F, et al. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosteronereceptor deficiency. Acta Endocrinol Suppl (Copenh) 1986;279:376-80.
20. 20. O'Brodovich H, Rafii B, Post M. Bioelectric properties of fetal alveolar epithelial monolayers. Am J Physiol 1990;258:L201-6.
21. + channel subunits in normal and cystic fibrosis airways. Am J Physiol 1995;269:C511-8.
22. + channel expression is one of the pathogenetic mechanisms leading to human neonatal respiratory distress syndrome. Proc Assoc Am Physicians 1996;108:345-55.
23. 23. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, et al. Early death due to defective neonatal lung liquid clearance in α-ENaC-deficient mice. Nat Genet 1996;12:325-8.
24. + channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A 1999;96:1727-31.
25. 25. Marthinsen L, Kornfalt R, Aili M, Andersson D, Westgren U, Schaedel C. Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Acta Paediatr 1998;87:472-4.
26. 26. Stewart B, Zabner J, Shuber AP, Welsh MJ, McCray PB Jr. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995;151:899-903.